[Transmural coronary blood flow redistribution in the non-ischemic and ischemic canine myocardium with S 2395, a beta-adrenoceptor blocking agent (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001578:Benzopyrans / Q000494:pharmacology*; D002839:Chromans / Q000008:administration & dosage / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000503:physiopathology*; D003331:Coronary Vessels / Q000502:physiology; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000033:anatomy & histology; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D009206:Myocardium / Q000378:metabolism; D011412:Propanolamines / Q000008:administration & dosage / Q000494:pharmacology*; D013876:Thiophenes
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D002839:Chromans; D011412:Propanolamines; D013876:Thiophenes; C005632:tertatolol
Rédistribution transmurale du débit sanguin coronaire du myocarde sain et/ou ischémique du chien sous l'influence d'un inhibiteur beta-adrénergique, le S 2395.